Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Derek J Royer, Alex W Cohen & Daniel JJ Carr. (2015) The current state of vaccine development for ocular HSV-1 infection. Expert Review of Ophthalmology 10:2, pages 113-126.
Read now
Read now
Shane C McAllister & Mark R Schleiss. (2014) Prospects and perspectives for development of a vaccine against herpes simplex virus infections. Expert Review of Vaccines 13:11, pages 1349-1360.
Read now
Read now
Articles from other publishers (18)
Mingming Wan, Xiao Yang, Jie Sun, Xue Ding, Zhijun Chen, Weiheng Su, Linjun Cai, Ali Hou, Bo Sun, Feng Gao, Chunlai Jiang & Yan Zhou. (2023) An Adenovirus-Based Recombinant Herpes Simplex Virus 2 (HSV-2) Therapeutic Vaccine Is Highly Protective against Acute and Recurrent HSV-2 Disease in a Guinea Pig Model. Viruses 15:1, pages 219.
Crossref
Crossref
Natalie L. M. Ramsey, Maria Visciano, Richard Hunte, Lip Nam Loh, Clare Burn Aschner, William R. JacobsJr.Jr. & Betsy C. Herold. (2020) A Single-Cycle Glycoprotein D Deletion Viral Vaccine Candidate, ΔgD-2, Elicits Polyfunctional Antibodies That Protect against Ocular Herpes Simplex Virus. Journal of Virology 94:13.
Crossref
Crossref
Derek J. Royer, Micaela L. Montgomery & Daniel J.J. Carr. 2020. Mucosal Vaccines. Mucosal Vaccines
299
312
.
H. M. H. N. Bandara & Lakshman P. Samaranayake. (2019) Viral, bacterial, and fungal infections of the oral mucosa: Types, incidence, predisposing factors, diagnostic algorithms, and management. Periodontology 2000 80:1, pages 148-176.
Crossref
Crossref
Derek J. Royer, Joshua F. Hendrix, Chelsea M. Larabee, Alaina M. Reagan, Virginie H. Sjoelund, Danielle M. Robertson & Daniel J.J. Carr. (2019) Vaccine-induced antibodies target sequestered viral antigens to prevent ocular HSV-1 pathogenesis, preserve vision, and preempt productive neuronal infection. Mucosal Immunology 12:3, pages 827-839.
Crossref
Crossref
David I. Bernstein, Derek A. Pullum, Rhonda D. Cardin, Fernando J. Bravo, David A. Dixon & Konstantin G. Kousoulas. (2019) The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes. Vaccine 37:1, pages 61-68.
Crossref
Crossref
David J. Davido, Eleain M. Tu, Hong Wang, Maria Korom, Andreu Gazquez Casals, P. Jahnu Reddy, Heba H. Mostafa, Benjamin Combs, Steve D. Haenchen & Lynda A. Morrison. (2018) Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease. Journal of Virology 92:17.
Crossref
Crossref
Xiaolong Zhang, Quanlong Jiang, Xingli Xu, Yongrong Wang, Lei Liu, Yaru Lian, Hao Li, Lichun Wang, Ying Zhang, Guorun Jiang, Jieyuan Zeng, Han Zhang, Jing-Dong Jackie Han & Qihan Li. (2018) Immune mechanisms induced by an HSV-1 mutant strain: Discrepancy analysis of the immune system gene profile in comparison with a wild-type strain. Vaccine 36:18, pages 2394-2402.
Crossref
Crossref
Derek J. Royer & Daniel J. J. Carr. (2017) Reply to “Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?”. Journal of Virology 91:23.
Crossref
Crossref
Derek J. Royer, Meghan M. Carr, Hem R. Gurung, William P. Halford & Daniel J. J. Carr. (2017) The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa. The Journal of Immunology 199:5, pages 1898-1911.
Crossref
Crossref
Derek J. Royer, Meghan M. Carr, Ana J. Chucair-Elliott, William P. Halford & Daniel J. J. Carr. (2017) Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice. Journal of Virology 91:7.
Crossref
Crossref
Kenneth C. BagleyJennifer A. SchwartzHanne AndersenJohn H. EldridgeRong XuAyuko Ota-SetlikJoshua J. GeltzWilliam P. HalfordTimothy R. Fouts. (2017) An Interleukin 12 Adjuvanted Herpes Simplex Virus 2 DNA Vaccine Is More Protective Than a Glycoprotein D Subunit Vaccine in a High-Dose Murine Challenge Model. Viral Immunology 30:3, pages 178-195.
Crossref
Crossref
Derek J. Royer, Christopher D. Conrady & Daniel J. J. Carr. (2016) Herpesvirus-Associated Lymphadenitis Distorts Fibroblastic Reticular Cell Microarchitecture and Attenuates CD8 T Cell Responses to Neurotropic Infection in Mice Lacking the STING-IFNα/β Defense Pathways. The Journal of Immunology 197:6, pages 2338-2352.
Crossref
Crossref
Francesco Nicoli, Eleonora Gallerani, Charalampos Skarlis, Mariaconcetta Sicurella, Aurelio Cafaro, Barbara Ensoli, Antonella Caputo, Peggy C. Marconi & Riccardo Gavioli. (2016) Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection. Vaccine 34:19, pages 2216-2224.
Crossref
Crossref
William P. Halford, Joshua Geltz, Ronald J. Messer & Kim J. Hasenkrug. (2015) Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2. PLOS ONE 10:12, pages e0145228.
Crossref
Crossref
Marina Boukhvalova, Jamall McKay, Aissatou Mbaye, Hannah Sanford-Crane, Jorge C. G. Blanco, Ashley Huber & Betsy C. Herold. (2015) Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model. Journal of Virology 89:19, pages 9825-9840.
Crossref
Crossref
Joshua J. Geltz, Edward Gershburg & William P. Halford. (2015) Herpes Simplex Virus 2 (HSV-2) Infected Cell Proteins Are among the Most Dominant Antigens of a Live-Attenuated HSV-2 Vaccine. PLOS ONE 10:2, pages e0116091.
Crossref
Crossref
Paula A. Suazo, Francisco J. Ibañez, Angello R. Retamal-Díaz, Marysol V. Paz-Fiblas, Susan M. Bueno, Alexis M. Kalergis & Pablo A. González. (2015) Evasion of Early Antiviral Responses by Herpes Simplex Viruses. Mediators of Inflammation 2015, pages 1-16.
Crossref
Crossref